Chan Nelson 4

What Happened Chan Nelson, a member of Twist Bioscience’s board of directors, was granted an annual equity award of 5,095 shares on February 5, 2026. The shares were reported as acquired at $0.00 per share (total reported value $0). This was an equity grant to a non-employee director rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-02-05 (Form 4 filed 2026-02-09).
• Transaction type/code: Award/Grant (A); price reported $0.00; 5,095 shares.
• Shares owned after transaction: not specified in the filing.
• Vesting note: Footnote states 100% of the shares will vest upon the earlier of (i) one-year anniversary of the grant and (ii) the first annual meeting of stockholders following the grant, provided the director remains a service provider on each vesting date.
• No late-filing flag is indicated in the information provided.

Context Grants to non-employee directors are a common form of compensation and typically carry vesting restrictions; they do not necessarily signal a buying or selling preference. Because these shares are subject to a vesting schedule, they may be restricted until vesting conditions are met.